Global Liver Disease Drug Sales Market Report 2016

December 2016 | 110 pages | ID: G41B3DC98B2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Liver Disease Drug

Revenue, means the sales value of Liver Disease Drug

This report studies sales (consumption) of Liver Disease Drug in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Bayer Schering AG
• Biotest
• Bristol-Myers Squibb
• Eli Lilly
• Glaxosmithkline PlC
• Merck & Co
• Pfizer
• Roche
• Valeant Pharmaceuticals International, Inc
• Chia Tai Tianqing Pharmaceutical Group
• Fujian Cosunter Pharmaceutical Company
• Beijing Sl Pharmaceutical Co., Ltd.
• Inner Mongolia Furui Medical Science Co. Ltd.

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Liver Disease Drug in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Liver Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Liver Disease Drug Sales Market Report 2016

1 LIVER DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Liver Disease Drug
1.2 Classification of Liver Disease Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Liver Disease Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Liver Disease Drug Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Liver Disease Drug (2011-2021)
  1.5.1 Global Liver Disease Drug Sales and Growth Rate (2011-2021)
  1.5.2 Global Liver Disease Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL LIVER DISEASE DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Liver Disease Drug Market Competition by Manufacturers
  2.1.1 Global Liver Disease Drug Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Liver Disease Drug Revenue and Share by Manufacturers (2011-2016)
2.2 Global Liver Disease Drug (Volume and Value) by Type
  2.2.1 Global Liver Disease Drug Sales and Market Share by Type (2011-2016)
  2.2.2 Global Liver Disease Drug Revenue and Market Share by Type (2011-2016)
2.3 Global Liver Disease Drug (Volume and Value) by Regions
  2.3.1 Global Liver Disease Drug Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Liver Disease Drug Revenue and Market Share by Regions (2011-2016)
2.4 Global Liver Disease Drug (Volume) by Application

3 UNITED STATES LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Liver Disease Drug Sales and Value (2011-2016)
  3.1.1 United States Liver Disease Drug Sales and Growth Rate (2011-2016)
  3.1.2 United States Liver Disease Drug Revenue and Growth Rate (2011-2016)
  3.1.3 United States Liver Disease Drug Sales Price Trend (2011-2016)
3.2 United States Liver Disease Drug Sales and Market Share by Manufacturers
3.3 United States Liver Disease Drug Sales and Market Share by Type
3.4 United States Liver Disease Drug Sales and Market Share by Application

4 CHINA LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Liver Disease Drug Sales and Value (2011-2016)
  4.1.1 China Liver Disease Drug Sales and Growth Rate (2011-2016)
  4.1.2 China Liver Disease Drug Revenue and Growth Rate (2011-2016)
  4.1.3 China Liver Disease Drug Sales Price Trend (2011-2016)
4.2 China Liver Disease Drug Sales and Market Share by Manufacturers
4.3 China Liver Disease Drug Sales and Market Share by Type
4.4 China Liver Disease Drug Sales and Market Share by Application

5 EUROPE LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Liver Disease Drug Sales and Value (2011-2016)
  5.1.1 Europe Liver Disease Drug Sales and Growth Rate (2011-2016)
  5.1.2 Europe Liver Disease Drug Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Liver Disease Drug Sales Price Trend (2011-2016)
5.2 Europe Liver Disease Drug Sales and Market Share by Manufacturers
5.3 Europe Liver Disease Drug Sales and Market Share by Type
5.4 Europe Liver Disease Drug Sales and Market Share by Application

6 JAPAN LIVER DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Liver Disease Drug Sales and Value (2011-2016)
  6.1.1 Japan Liver Disease Drug Sales and Growth Rate (2011-2016)
  6.1.2 Japan Liver Disease Drug Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Liver Disease Drug Sales Price Trend (2011-2016)
6.2 Japan Liver Disease Drug Sales and Market Share by Manufacturers
6.3 Japan Liver Disease Drug Sales and Market Share by Type
6.4 Japan Liver Disease Drug Sales and Market Share by Application

7 GLOBAL LIVER DISEASE DRUG MANUFACTURERS ANALYSIS

7.1 Bayer Schering AG
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Liver Disease Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bayer Schering AG Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Biotest
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 110 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Biotest Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Bristol-Myers Squibb
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 135 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bristol-Myers Squibb Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Eli Lilly
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Eli Lilly Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Glaxosmithkline PlC
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Glaxosmithkline PlC Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Merck & Co
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Merck & Co Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Pfizer
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharmaceuticals Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Pfizer Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Roche
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Roche Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Valeant Pharmaceuticals International, Inc
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Valeant Pharmaceuticals International, Inc Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Chia Tai Tianqing Pharmaceutical Group
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Chia Tai Tianqing Pharmaceutical Group Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Fujian Cosunter Pharmaceutical Company
7.12 Beijing Sl Pharmaceutical Co., Ltd.
7.13 Inner Mongolia Furui Medical Science Co. Ltd.

8 LIVER DISEASE DRUG MAUFACTURING COST ANALYSIS

8.1 Liver Disease Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Liver Disease Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Liver Disease Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Liver Disease Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL LIVER DISEASE DRUG MARKET FORECAST (2016-2021)

12.1 Global Liver Disease Drug Sales, Revenue Forecast (2016-2021)
12.2 Global Liver Disease Drug Sales Forecast by Regions (2016-2021)
12.3 Global Liver Disease Drug Sales Forecast by Type (2016-2021)
12.4 Global Liver Disease Drug Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liver Disease Drug
Table Classification of Liver Disease Drug
Figure Global Sales Market Share of Liver Disease Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Liver Disease Drug
Figure Global Sales Market Share of Liver Disease Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure China Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Europe Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Japan Liver Disease Drug Revenue and Growth Rate (2011-2021)
Figure Global Liver Disease Drug Sales and Growth Rate (2011-2021)
Figure Global Liver Disease Drug Revenue and Growth Rate (2011-2021)
Table Global Liver Disease Drug Sales of Key Manufacturers (2011-2016)
Table Global Liver Disease Drug Sales Share by Manufacturers (2011-2016)
Figure 2015 Liver Disease Drug Sales Share by Manufacturers
Figure 2016 Liver Disease Drug Sales Share by Manufacturers
Table Global Liver Disease Drug Revenue by Manufacturers (2011-2016)
Table Global Liver Disease Drug Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Liver Disease Drug Revenue Share by Manufacturers
Table 2016 Global Liver Disease Drug Revenue Share by Manufacturers
Table Global Liver Disease Drug Sales and Market Share by Type (2011-2016)
Table Global Liver Disease Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Liver Disease Drug by Type (2011-2016)
Figure Global Liver Disease Drug Sales Growth Rate by Type (2011-2016)
Table Global Liver Disease Drug Revenue and Market Share by Type (2011-2016)
Table Global Liver Disease Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Liver Disease Drug by Type (2011-2016)
Figure Global Liver Disease Drug Revenue Growth Rate by Type (2011-2016)
Table Global Liver Disease Drug Sales and Market Share by Regions (2011-2016)
Table Global Liver Disease Drug Sales Share by Regions (2011-2016)
Figure Sales Market Share of Liver Disease Drug by Regions (2011-2016)
Figure Global Liver Disease Drug Sales Growth Rate by Regions (2011-2016)
Table Global Liver Disease Drug Revenue and Market Share by Regions (2011-2016)
Table Global Liver Disease Drug Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Liver Disease Drug by Regions (2011-2016)
Figure Global Liver Disease Drug Revenue Growth Rate by Regions (2011-2016)
Table Global Liver Disease Drug Sales and Market Share by Application (2011-2016)
Table Global Liver Disease Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Liver Disease Drug by Application (2011-2016)
Figure Global Liver Disease Drug Sales Growth Rate by Application (2011-2016)
Figure United States Liver Disease Drug Sales and Growth Rate (2011-2016)
Figure United States Liver Disease Drug Revenue and Growth Rate (2011-2016)
Figure United States Liver Disease Drug Sales Price Trend (2011-2016)
Table United States Liver Disease Drug Sales by Manufacturers (2011-2016)
Table United States Liver Disease Drug Market Share by Manufacturers (2011-2016)
Table United States Liver Disease Drug Sales by Type (2011-2016)
Table United States Liver Disease Drug Market Share by Type (2011-2016)
Table United States Liver Disease Drug Sales by Application (2011-2016)
Table United States Liver Disease Drug Market Share by Application (2011-2016)
Figure China Liver Disease Drug Sales and Growth Rate (2011-2016)
Figure China Liver Disease Drug Revenue and Growth Rate (2011-2016)
Figure China Liver Disease Drug Sales Price Trend (2011-2016)
Table China Liver Disease Drug Sales by Manufacturers (2011-2016)
Table China Liver Disease Drug Market Share by Manufacturers (2011-2016)
Table China Liver Disease Drug Sales by Type (2011-2016)
Table China Liver Disease Drug Market Share by Type (2011-2016)
Table China Liver Disease Drug Sales by Application (2011-2016)
Table China Liver Disease Drug Market Share by Application (2011-2016)
Figure Europe Liver Disease Drug Sales and Growth Rate (2011-2016)
Figure Europe Liver Disease Drug Revenue and Growth Rate (2011-2016)
Figure Europe Liver Disease Drug Sales Price Trend (2011-2016)
Table Europe Liver Disease Drug Sales by Manufacturers (2011-2016)
Table Europe Liver Disease Drug Market Share by Manufacturers (2011-2016)
Table Europe Liver Disease Drug Sales by Type (2011-2016)
Table Europe Liver Disease Drug Market Share by Type (2011-2016)
Table Europe Liver Disease Drug Sales by Application (2011-2016)
Table Europe Liver Disease Drug Market Share by Application (2011-2016)
Figure Japan Liver Disease Drug Sales and Growth Rate (2011-2016)
Figure Japan Liver Disease Drug Revenue and Growth Rate (2011-2016)
Figure Japan Liver Disease Drug Sales Price Trend (2011-2016)
Table Japan Liver Disease Drug Sales by Manufacturers (2011-2016)
Table Japan Liver Disease Drug Market Share by Manufacturers (2011-2016)
Table Japan Liver Disease Drug Sales by Type (2011-2016)
Table Japan Liver Disease Drug Market Share by Type (2011-2016)
Table Japan Liver Disease Drug Sales by Application (2011-2016)
Table Japan Liver Disease Drug Market Share by Application (2011-2016)
Table Bayer Schering AG Basic Information List
Table Bayer Schering AG Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Schering AG Liver Disease Drug Global Market Share (2011-2016)
Table Biotest Basic Information List
Table Biotest Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biotest Liver Disease Drug Global Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Liver Disease Drug Global Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Liver Disease Drug Global Market Share (2011-2016)
Table Glaxosmithkline PlC Basic Information List
Table Glaxosmithkline PlC Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Glaxosmithkline PlC Liver Disease Drug Global Market Share (2011-2016)
Table Merck & Co Basic Information List
Table Merck & Co Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co Liver Disease Drug Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Liver Disease Drug Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Liver Disease Drug Global Market Share (2011-2016)
Table Valeant Pharmaceuticals International, Inc Basic Information List
Table Valeant Pharmaceuticals International, Inc Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Valeant Pharmaceuticals International, Inc Liver Disease Drug Global Market Share (2011-2016)
Table Chia Tai Tianqing Pharmaceutical Group Basic Information List
Table Chia Tai Tianqing Pharmaceutical Group Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Chia Tai Tianqing Pharmaceutical Group Liver Disease Drug Global Market Share (2011-2016)
Table Fujian Cosunter Pharmaceutical Company Basic Information List
Table Fujian Cosunter Pharmaceutical Company Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Fujian Cosunter Pharmaceutical Company Liver Disease Drug Global Market Share (2011-2016)
Table Beijing Sl Pharmaceutical Co., Ltd. Basic Information List
Table Beijing Sl Pharmaceutical Co., Ltd. Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Beijing Sl Pharmaceutical Co., Ltd. Liver Disease Drug Global Market Share (2011-2016)
Table Inner Mongolia Furui Medical Science Co. Ltd. Basic Information List
Table Inner Mongolia Furui Medical Science Co. Ltd. Liver Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Inner Mongolia Furui Medical Science Co. Ltd. Liver Disease Drug Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liver Disease Drug
Figure Manufacturing Process Analysis of Liver Disease Drug
Figure Liver Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Liver Disease Drug Major Manufacturers in 2015
Table Major Buyers of Liver Disease Drug
Table Distributors/Traders List
Figure Global Liver Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure Global Liver Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Liver Disease Drug Sales Forecast by Regions (2016-2021)
Table Global Liver Disease Drug Sales Forecast by Type (2016-2021)
Table Global Liver Disease Drug Sales Forecast by Application (2016-2021)